Janesville’s SHINE announced the launch of Ilumira, its first branded medical isotope product. The milestone represents over 10 years of work and innovation.
Ilumira is a revolutionary radioisotope. When paired with a cancer-seeking molecule, it precisely targets tumors and metastases and delivers a powerful dose of radiation to kill cancer cells while minimizing harm to healthy tissue.
Ilumira can transform cancer care by:
-
Illuminating and treating cancer as part of a powerful theranostic technique; and
-
Addressing supply chain challenges in the medical isotope industry.
Ilumira will be used in clinical trials.
